Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Akari Therapeutics PLC (AKTX) had Weighted-Average Shares Outstanding (Diluted) of 11.94M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-19.79M |
|
-- |
|
-- |
|
$21.64M |
|
$-21.64M |
|
$1.85M |
|
$-19.79M |
|
$-19.79M |
|
$-19.79M |
|
$-19.79M |
|
$-19.79M |
|
$-19.79M |
|
$-21.64M |
|
$-21.63M |
|
11.94M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.94M |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$2.95M |
|
-- |
|
$47.61M |
|
$50.56M |
|
$19.91M |
|
-- |
|
$8.42M |
|
$28.33M |
|
$22.23M |
|
$-25.38M |
|
$22.23M |
|
26.59M |
|
| Cash Flow Statement Financials | |
$-12.55M |
|
$0.38M |
|
$10.99M |
|
$3.85M |
|
$2.66M |
|
$-1.19M |
|
$2.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-89.03% |
|
77.98% |
|
-39.14% |
|
-89.03% |
|
$0.84 |
|
$-1.05 |
|
$-1.05 |
|